ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	30/136	233/7206	1.83746869637e-17
ko05200	Pathways in cancer	39/136	492/7206	3.08000036776e-15
ko05217	Basal cell carcinoma	14/136	68/7206	1.91646064856e-11
ko04390	Hippo signaling pathway	20/136	188/7206	2.47186528879e-10
ko04310	Wnt signaling pathway	18/136	181/7206	6.28808882867e-09
ko04151	PI3K-Akt signaling pathway	25/136	390/7206	5.19809581677e-08
ko04550	Signaling pathways regulating pluripotency of stem cells	16/136	165/7206	6.68442387749e-08
ko05205	Proteoglycans in cancer	20/136	271/7206	1.38940078559e-07
ko05224	Breast cancer	16/136	174/7206	1.40925534938e-07
ko04340	Hedgehog signaling pathway	9/136	58/7206	1.13326284594e-06
ko05206	MicroRNAs in cancer	14/136	177/7206	5.42408140163e-06
ko04512	ECM-receptor interaction	9/136	79/7206	1.56653383341e-05
ko05212	Pancreatic cancer	9/136	83/7206	2.34725788736e-05
ko05220	Chronic myeloid leukemia	9/136	85/7206	2.84798102988e-05
ko05222	Small cell lung cancer	9/136	89/7206	4.12512822306e-05
ko04510	Focal adhesion	15/136	240/7206	4.21713546891e-05
ko05166	HTLV-I infection	16/136	292/7206	0.000112471591935
ko04391	Hippo signaling pathway - fly	8/136	90/7206	0.000276367441628
ko04150	mTOR signaling pathway	11/136	184/7206	0.000677671721926
ko04350	TGF-beta signaling pathway	8/136	103/7206	0.00069044553121
ko04520	Adherens junction	8/136	103/7206	0.00069044553121
ko04015	Rap1 signaling pathway	14/136	278/7206	0.000721515984936
ko01521	EGFR tyrosine kinase inhibitor resistance	8/136	106/7206	0.00083531150965
ko04933	AGE-RAGE signaling pathway in diabetic complications	9/136	135/7206	0.000976024636375
ko05210	Colorectal cancer	7/136	86/7206	0.00113579088125
ko04916	Melanogenesis	9/136	142/7206	0.00139570331173
ko05145	Toxoplasmosis	8/136	126/7206	0.00253930285514
ko04392	Hippo signaling pathway -multiple species	4/136	31/7206	0.00257172710041
ko04722	Neurotrophin signaling pathway	9/136	160/7206	0.00316491339126
ko04068	FoxO signaling pathway	9/136	167/7206	0.00420640266952
ko04080	Neuroactive ligand-receptor interaction	1/136	423/7206	0.00479683058536
ko05215	Prostate cancer	7/136	111/7206	0.00486621629292
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3/136	19/7206	0.00510639139094
ko05218	Melanoma	6/136	85/7206	0.00522527057259
ko05161	Hepatitis B	9/136	173/7206	0.00529757062664
ko04341	Hedgehog signaling pathway - fly	4/136	38/7206	0.00544964522764
ko04110	Cell cycle	8/136	145/7206	0.00597581743511
ko04218	Cellular senescence	9/136	177/7206	0.00613919628605
ko04014	Ras signaling pathway	12/136	279/7206	0.00628462504273
ko05211	Renal cell carcinoma	6/136	96/7206	0.00936470487174
ko05146	Amoebiasis	6/136	99/7206	0.0108139189407
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/136	26/7206	0.0124469884958
ko04380	Osteoclast differentiation	7/136	134/7206	0.0131763587655
ko05140	Leishmaniasis	5/136	75/7206	0.0133646907504
ko05230	Central carbon metabolism in cancer	5/136	81/7206	0.0181487201176
ko00514	Other types of O-glycan biosynthesis	3/136	30/7206	0.0184038695463
ko05131	Shigellosis	5/136	82/7206	0.0190427975081
ko04917	Prolactin signaling pathway	5/136	87/7206	0.0239479500315
ko04974	Protein digestion and absorption	5/136	96/7206	0.034689880467
ko05142	Chagas disease (American trypanosomiasis)	6/136	130/7206	0.0360044141529
ko04514	Cell adhesion molecules (CAMs)	6/136	130/7206	0.0360044141529
ko05410	Hypertrophic cardiomyopathy (HCM)	5/136	100/7206	0.040287312648
ko04024	cAMP signaling pathway	10/136	279/7206	0.0421944880176
ko04659	Th17 cell differentiation	5/136	106/7206	0.0496605011939